Moreover, EpCAM+ CTCs from colorectal cancer have been reported to fuse with macrophages to form CD45+ circulating hybrid cells, which exhibited increased tumor heterogeneity and metastatic behavior [48]. This evidence concerns the gene PTPRC and colorectal cancer.